Article Type
Article
Changed
Thu, 12/15/2022 - 15:14
Display Headline
HRT and Ovarian Cancer: How Does Dose Affect Risk?

Article PDF
022020062.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(2)
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Oncology
Page Number
62
Legacy Keywords
HRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomyHRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomy
Sections
Pharmacology
Clinical Topics & News
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022020062.pdf
Article PDF
022020062.pdf

Issue
Federal Practitioner - 22(2)
Issue
Federal Practitioner - 22(2)
Page Number
62
Page Number
62
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Oncology
Article Type
Article
Display Headline
HRT and Ovarian Cancer: How Does Dose Affect Risk?
Display Headline
HRT and Ovarian Cancer: How Does Dose Affect Risk?
Legacy Keywords
HRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomyHRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomy
Legacy Keywords
HRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomyHRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomy
Sections
Pharmacology
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media